出典: meddic

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/01/15 23:32:34」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • 6-Mercaptopurine transport by equilibrative nucleoside transporters in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBTs.
  • Lee NY, Sai Y, Nakashima E, Ohtsuki S, Kang YS.SourceCollege of Pharmacy and Research Institute of Pharmaceutical Science, Sookmyung Women's University, Seoul, Korea.
  • Journal of pharmaceutical sciences.J Pharm Sci.2011 Sep;100(9):3773-82. doi: 10.1002/jps.22631. Epub 2011 May 17.
  • Recently, more women were provided with 6-mercaptopurine (6-MP) during pregnancy. Therefore, we attempted to clarify the transport mechanisms of 6-MP through blood-placenta barrier using rat conditionally immortalized syncytiotrophoblast cell lines (TR-TBTs). The uptake of 6-MP was time- and ATP dep
  • PMID 21590775
  • Management of Gout in the Older Adult.
  • Fravel MA, Ernst ME.SourceDepartment of Pharmacy Practice and Science, College of Pharmacy, The University of Iowa, Iowa City, Iowa.
  • The American journal of geriatric pharmacotherapy.Am J Geriatr Pharmacother.2011 Aug 15. [Epub ahead of print]
  • BACKGROUND: Gout affects 3 million people in the United States, with rates almost 5 times higher in those aged 70 to 79 years compared with those aged <50 years. Management of gout in elderly subjects can be complicated by comorbidities and polypharmacy.OBJECTIVE: The purpose of this article was
  • PMID 21849262


  • 6-Deoxy-6-[131I]iodo-L-ascorbic Acid for the in Vivo Study of Ascorbate: Autoradiography, Biodistribution in Normal and Hypolipidemic Rats, and in Tumor-Bearing Nude Mice
  • Kim Jintaek,Yamamoto Fumihiko,Gondo Shigeki,Yanase Toshihiko,Mukai Takahiro,Maeda Minoru
  • Biological & Pharmaceutical Bulletin 32(11), 1906-1911, 2009
  • … Preinjection of sulfinpyrazone, a known blocker of ascorbate transport, with 6-131IAsA resulted in decreased uptake of radioactivity in rat adrenal glands compared to the control group, seemingly illustrating the participation of the SVCT transporter (probably the SVCT-2 subtype) in the uptake process in vivo. …
  • NAID 130000116966
  • 血漿たん白質への薬物の結合の競合が原因となる薬物相互作用の臨床的意味に関する理論的, 文献的考察 : ワルファリン
  • 緒方 宏泰,太田 稔邦
  • 病院薬学 22(3), 221-229, 1996-06-10
  • … Phenylbutazone and sulfinpyrazone were clarified to reduce the hepatic metabolism of warfarin, although they also reduced its protein binding. …
  • NAID 110001799571


Like other uricosurics, sulfinpyrazone works by competitively inhibiting uric acid reabsorption in the proximal tubule of the kidney. ... Sulfinpyrazone must not be used in persons with renal impairment or a high rate of excretion of uric acid ...


 Apo-Sulfinpyrazone, Novopyrazone, Zynolsulfinpyrazone藥品圖示及外觀說明 Apo-Sulfinpyrazone, Novopyrazone, ZynolSulfinpyrazoneDescription Sulfinpyrazone.svg




1マーフィー徴候 18
2narrow segment 16
3" wounds are made"  15
4グレイ症候群 15
5"phenoxypolyethoxylethanol" 15
6ロイシンエンケファリン 13
7硝酸ミコナゾール 11
8Common Laboratory Equipment 11
9content 10
10だいすいたいしんけい 9
11粟粒結核と肉下種 9
12全身性ヒマン細胞小 9
13細胞内寄生菌 9
14kligler培地 原理 9
15不整脈  9
16角膜反射 中枢 9
17膜性骨化 8
18ソルデム 8
19ハプロ不全 疾患 8
20日本多毛 8

1" wounds are made"  15
2kligler培地 原理 9
3kligler培地 硫化鉄 4
4ǸCαꥦ륹ΤǤ뤳ȤŦƤ֤Ƥ 4
5歳の女性。右目の疼痛、充血および霧視を主訴に来院した。眼底に異常を認めない。視力は右 0.9 (矯正不能)、左 1.2 (矯正不能)。眼圧は右 11 mmHg、左 12 mmHg。フルオレセイン染色後の前眼部写真 (別冊No. 5) を別に示す。 治療薬として適切なのはどれか。 4
6胃癌 borrmann分類 3
7回復過程 3
8ジェンドラシック法 メカニズム 3
9しょうすいたいしんけい 3
10ラリンゲルマスク ゼリー 3
11ハッセルバッハ三角 3
12白内障 grade 3
13フォンギールケ病 3
14マッコーネルサイン 3
15小児骨折 好発部位 3
16咽頭神経叢 3
17低アルドステロン症 3
18フロマン徴候 3
19オーグメンチン 販売中止 3
20クスマウル徴候 3